Abdul-Aziz, N., Abdulhameed, N., Marellapudi, A. and Shah, H. 2023. Multiple Sclerosis anti-CD20 (Ocrelizumab) therapy inducing hypogammaglobulinemia. Translation: The University of Toledo Journal of Medical Sciences. 11, 3 (Dec. 2023). DOI:https://doi.org/10.46570/utjms.vol11-2023-836.